RxDoctor Payments Data

Pritha Ghosh, MD

Neurology · Washington, DCNPI 1932241957

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $503 and has fallen 86.6% since, to $67 in 2025. That places this record below the midpoint for neurology clinicians in DC, where the typical reported total is $1,102.

$1,091in general payments, 2019–2025

Across 23 payments — averaging $47.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$226
  • Neurocrine Biosciences, Inc.$166
  • Boston Scientific$126
  • Acadia Pharmaceuticals Inc$123
  • MDD US Operations, LLC$115
  • Insightec,inc$110
  • plus $224 from 6 others
$42,000in research payments, 2019–2025

Across 8 payments — averaging $5250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$42K

What the payments were for

  • Travel & lodging$272%
  • Food & beverage$1,06498%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,091 in reported general payments places this provider in the 45th percentile of 113 neurology providers in District of Columbia.

See all neurology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$81,583
Medicare patients
88
Services billed
7,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa17$27,512
NeuproRotigotine18$16,594
Carbidopa-LevodopaCarbidopa/Levodopa188$7,783
Midodrine Hcl17$2,432
Carbidopa-Levodopa ErCarbidopa/Levodopa54$1,905
Rasagiline Mesylate12$1,226
Primidone30$1,020
Clonazepam30$729
Mirtazapine11$559
Gabapentin43$473
Baclofen22$463
Donepezil Hcl17$334
Propranolol Hcl ErPropranolol Hcl15$295
Atorvastatin Calcium13$271
Sertraline Hcl11$18

Paid to pharmacies, not to this prescriber.

Other neurology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →